FIT BIOTECH LTD: SHARES SUBSCRIBED WITH CONVERTIBLE CAPITAL

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FIT BIOTECH LTD: SHARES SUBSCRIBED WITH CONVERTIBLE CAPITAL LOAN

EXCHANGE NOTICE, 16 DECEMBER 2016  SHARES FIT BIOTECH LTD: SHARES SUBSCRIBED WITH CONVERTIBLE CAPITAL LOAN A total of 478 240 K shares subscribed with the convertible capital loan of FIT Biotech Ltd will be traded on First North Finland together with the old K shares as of 19 December 2016. Identifiers of FIT Biotech Ltd's K share: Trading code: FITBIO ISIN code: FI4000148606 Orderbook id: 109536 Amount: 40 825 532 Nasdaq Helsinki Oy, Issuer Surveillance, survo@nasdaq.com, +358 9 6166 7260 * * * * * * * * * * * * * * * * * TIEDOTE, 16.12.2016  OSAKKEET FIT BIOTECH OY: VAIHDETTAVALLA PÄÄOMALAINALLA MERKITYT OSAKKEET FIT Biotech Oy:n vaihdettavalla pääomalainalla merkityt yhteensä 478.240 K-osaketta otetaan kaupankäynnin kohteeksi First North Finland -markkinapaikalle yhdessä vanhojen K-osakkeiden kanssa 19.12.2016 alkaen. FIT Biotech Oy:n K-osakkeen perustiedot: Kaupankäyntitunnus: FITBIO ISIN-koodi: FI4000148606 id: 109536 Osakkeiden lukumäärä: 40.825.532 Nasdaq Helsinki Oy, Issuer Surveillance, survo@nasdaq.com, +358 9 6166 7260

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Sales Focus Inc. Awarded as Leading Medical Outsourcing Service

Updated Category News Views 112

Sales Focus Inc.: Leading the Way in Healthcare Outsourcing Sales Focus Inc. (SFI) proudly announces its recognition as the Top Healthcare and Medical Sales Outsourcing Service for 2025. This prestigious accolade showcases the company's vital role in revolutionizing the healthcare sector with its innovative full-lifecycle sales execution model and robust industry...

Continue Reading
The Rise of Autonomous Data Platforms in the Tech Industry

Updated Category News Views 76

Exploring the Autonomous Data Platform Market Growth The world of data management is rapidly evolving, with the Autonomous Data Platform Market projected to reach an impressive USD 14.96 billion by 2032. This explosive growth expands at a significant CAGR of 27.89% from its current valuation, representing a fundamental shift in how organizations interact with their data....

Continue Reading
Enpro's Recent Insider Activity Signals Strong Future Potential

Updated Category News Views 177

Insider Purchase by William Abbey at Enpro In the latest SEC filing, the market received noteworthy news about Enpro. William Abbey, who serves as a Director at Enpro (NYSE:NPO), demonstrated significant confidence in the company by purchasing 567 shares for a total of $139,997. What This Purchase Indicates This insider transaction suggests a strong belief in Enpro's...

Continue Reading
Massive Increase in BNB Fund for Cancer Patients Unveiled

Updated Category News Views 168

BNB Donation Achieves Remarkable Growth Recently, an incredible story surfaced about the untouched donation made in BNB (CRYPTO: BNB) for cancer patients. This donation, originally valued at $200,000, has soared to an astonishing $39 million thanks to the surging market value of cryptocurrencies, particularly BNB. Impact of Cryptocurrency Fluctuation on Charity Funds...

Continue Reading
Bio X Cell Refreshes Brand Identity to Enhance Global Research Impact

Updated Category News Views 171

Bio X Cell Unveils a Fresh Brand Identity Bio X Cell, recognized as the global leader in functional antibodies tailored for in vivo and emerging preclinical models, has introduced a modernized brand identity. This change is a testament to nearly three decades of excellence in the field, seamlessly merging scientific innovation with expanding global capabilities in...

Continue Reading